Toll Free: 1-888-928-9744

Global and Europe Inactivated Vaccine Market - Analysis and Outlook to 2022

Published: Aug 9, 2017 | Pages: 114 | Publisher: EU Research | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report presents a comprehensive overview of the Inactivated Vaccine market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Inactivated Vaccine industry.

This report focuses Global and Europe market,  including details as following:

Key Players

•	Astellas Pharma (Japan)
•	CSL Limited (Australia)
•	Emergent BioSolutions (U.S.)
•	GlaxoSmithKline (U.K.)
•	Johnson & Johnson (U.S.)
•	MedImmune (U.S.)
•	Merck & Co (U.S.)
•	Pfizer (U.S.)
•	Sanofi Pasteur (France)
•	Serum Institute of India Pvt (India)

Key Regions

•	North America
•	United States
•	Canada
•	Latin America
•	Mexico
•	Brazil
•	Argentina
•	Others
•	Europe
•	Germany
•	United Kingdom
•	France
•	Italy
•	Spain
•	Russia
•	Netherland
•	Others
•	Asia & Pacific
•	China
•	Japan
•	India
•	Korea
•	Australia
•	Southeast Asia
•	Indonesia
•	Thailand
•	Philippines
•	Vietnam
•	Singapore
•	Malaysia
•	Others
•	Africa & Middle East
•	South Africa
•	Egypt
•	Turkey
•	Saudi Arabia
•	Iran
•	Others

Key Product Type

•	By End User: Pediatrics, Adults.
•	By Disease Indication: Pneumococcal, Influenza, HPV, Hepatitis, Rotavirus.

Key Applications

•	Hospital
•	Medical Center
 Table of Contents

Global and Europe Inactivated Vaccine Market - Analysis and Outlook to 2022

1 Market Outline
    1.1 Research Methodology
        1.1.1 Methodology/Research Approach
            Research Programs/Design
            Market Size Estimation
            Market Breakdown and Data Triangulation
        1.1.2 Data Source
            Secondary Sources
            Primary Sources
        1.1.3 Disclaimer
    1.2 Regulatory Factors
    1.3 End-User Analysis
    1.4 Strategic Benchmarking
    1.5 Industry Chain and Supply Chain
        1.5.1 Inactivated Vaccine Industry Chain Structure
            1.5.1.1 R&D
            1.5.1.2 Raw Materials (Components)
            1.5.1.3 Manufacturing Plants
            1.5.1.4 Regional Trading (Import Export and Local Sales)
            1.5.1.5 Online Sales Channel
            1.5.1.6 Offline Channel
            1.5.1.7 End Users
        1.5.2 Inactivated Vaccine Manufacturing
            1.5.2.1 Key Components
            1.5.2.2 Assembly Manufacturing
        1.5.3 Consumer Preference
        1.5.4 Behavioral Habits
        1.5.5 Marketing Environment
    1.6 SWOT Analysis
    1.7 Feasibility Analysis
    1.8 Development Trend and Research Conclusion
        1.8.1 Development Trend
        1.8.2 Research Conclusion

2 Global Inactivated Vaccine Product Overview
    2.1 Global Inactivated Vaccine Market Sales Volume Revenue and Price 2012-2017
    2.2 Inactivated Vaccine, by End User 2012-2017
        2.2.1 Global Inactivated Vaccine Sales Market Share by End User 2012-2017
        2.2.2 Global Inactivated Vaccine Revenue Market Share by End User 2012-2017
        2.2.3 Global Inactivated Vaccine Price by End User 2012-2017
        2.2.4 Pediatrics
        2.2.5 Adults
    2.3 Inactivated Vaccine, by Disease Indication 2012-2017
        2.3.1 Global Inactivated Vaccine Sales Market Share by Disease Indication 2012-2017
        2.3.2 Global Inactivated Vaccine Revenue Market Share by Disease Indication 2012-2017
        2.3.3 Global Inactivated Vaccine Price by Disease Indication 2012-2017
        2.3.4 Pneumococcal
        2.3.5 Influenza
        2.3.6 HPV
        2.3.7 Hepatitis
        2.3.8 Rotavirus

3 Europe Inactivated Vaccine Product Overview
    3.1 Europe Inactivated Vaccine Market Sales Volume Revenue and Price 2012-2017
    3.2 Inactivated Vaccine, by End User 2012-2017
        3.2.1 Europe Inactivated Vaccine Sales Market Share by End User 2012-2017
        3.2.2 Europe Inactivated Vaccine Revenue Market Share by End User 2012-2017
        3.2.3 Europe Inactivated Vaccine Price by End User 2012-2017
        3.2.4 Pediatrics
        3.2.5 Adults
    3.3 Inactivated Vaccine, by Disease Indication 2012-2017
        3.3.1 Europe Inactivated Vaccine Sales Market Share by Disease Indication 2012-2017
        3.3.2 Europe Inactivated Vaccine Revenue Market Share by Disease Indication 2012-2017
        3.3.3 Europe Inactivated Vaccine Price by Disease Indication 2012-2017
        3.3.4 Pneumococcal
        3.3.5 Influenza
        3.3.6 HPV
        3.3.7 Hepatitis
        3.3.8 Rotavirus

4 Inactivated Vaccine Top Companies Profile
    4.1 Astellas Pharma (Japan)
        4.1.1 Astellas Pharma (Japan) Company Details and Competitors
        4.1.2 Astellas Pharma (Japan) Key Inactivated Vaccine Models and Performance
        4.1.3 Astellas Pharma (Japan) Inactivated Vaccine Business SWOT Analysis and Forecast
        4.1.4 Astellas Pharma (Japan) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    4.2 CSL Limited (Australia)
        4.2.1 CSL Limited (Australia) Company Details and Competitors
        4.2.2 CSL Limited (Australia) Key Inactivated Vaccine Models and Performance
        4.2.3 CSL Limited (Australia) Inactivated Vaccine Business SWOT Analysis and Forecast
        4.2.4 CSL Limited (Australia) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    4.3 Emergent BioSolutions (U.S.)
        4.3.1 Emergent BioSolutions (U.S.) Company Details and Competitors
        4.3.2 Emergent BioSolutions (U.S.) Key Inactivated Vaccine Models and Performance
        4.3.3 Emergent BioSolutions (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
        4.3.4 Emergent BioSolutions (U.S.) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    4.4 GlaxoSmithKline (U.K.)
        4.4.1 GlaxoSmithKline (U.K.) Company Details and Competitors
        4.4.2 GlaxoSmithKline (U.K.) Key Inactivated Vaccine Models and Performance
        4.4.3 GlaxoSmithKline (U.K.) Inactivated Vaccine Business SWOT Analysis and Forecast
        4.4.4 GlaxoSmithKline (U.K.) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    4.5 Johnson & Johnson (U.S.)
        4.5.1 Johnson & Johnson (U.S.) Company Details and Competitors
        4.5.2 Johnson & Johnson (U.S.) Key Inactivated Vaccine Models and Performance
        4.5.3 Johnson & Johnson (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
        4.5.4 Johnson & Johnson (U.S.) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    4.6 MedImmune (U.S.)
        4.6.1 MedImmune (U.S.) Company Details and Competitors
        4.6.2 MedImmune (U.S.) Key Inactivated Vaccine Models and Performance
        4.6.3 MedImmune (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
        4.6.4 MedImmune (U.S.) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    4.7 Merck & Co (U.S.)
        4.7.1 Merck & Co (U.S.) Company Details and Competitors
        4.7.2 Merck & Co (U.S.) Key Inactivated Vaccine Models and Performance
        4.7.3 Merck & Co (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
        4.7.4 Merck & Co (U.S.) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    4.8 Pfizer (U.S.)
        4.8.1 Pfizer (U.S.) Company Details and Competitors
        4.8.2 Pfizer (U.S.) Key Inactivated Vaccine Models and Performance
        4.8.3 Pfizer (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
        4.8.4 Pfizer (U.S.) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    4.9 Sanofi Pasteur (France)
        4.9.1 Sanofi Pasteur (France) Company Details and Competitors
        4.9.2 Sanofi Pasteur (France) Key Inactivated Vaccine Models and Performance
        4.9.3 Sanofi Pasteur (France) Inactivated Vaccine Business SWOT Analysis and Forecast
        4.9.4 Sanofi Pasteur (France) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin
    4.10 Serum Institute of India Pvt (India)
        4.10.1 Serum Institute of India Pvt (India) Company Details and Competitors
        4.10.2 Serum Institute of India Pvt (India) Key Inactivated Vaccine Models and Performance
        4.10.3 Serum Institute of India Pvt (India) Inactivated Vaccine Business SWOT Analysis and Forecast
        4.10.4 Serum Institute of India Pvt (India) Inactivated Vaccine Sales Volume Revenue Price Cost and Gross Margin

5 Inactivated Vaccine by Regions 2012-2017
    5.1 Global Inactivated Vaccine Sales Market Share by Regions 2012-2017
    5.2 Global Inactivated Vaccine Revenue Market Share by Regions 2012-2017
    5.3 Global Inactivated Vaccine Price by Regions 2012-2017
    5.4 North America
        5.4.1 United States
        5.4.2 Canada
    5.5 Latin America
        5.5.1 Mexico
        5.5.2 Brazil
        5.5.3 Argentina
        5.5.4 Others in Latin America
    5.6 Europe
        5.6.1 Germany
        5.6.2 United Kingdom
        5.6.3 France
        5.6.4 Italy
        5.6.5 Spain
        5.6.6 Russia
        5.6.7 Netherland
        5.6.8 Others in Europe
    5.7 Asia & Pacific
        5.7.1 China
        5.7.2 Japan
        5.7.3 India
        5.7.4 Korea
        5.7.5 Australia
        5.7.6 Southeast Asia
            5.7.6.1 Indonesia
            5.7.6.2 Thailand
            5.7.6.3 Philippines
            5.7.6.4 Vietnam
            5.7.6.5 Singapore
            5.7.6.6 Malaysia
            5.7.6.7 Others in Southeast Asia
    5.8 Africa & Middle East
        5.8.1 South Africa
        5.8.2 Egypt
        5.8.3 Turkey
        5.8.4 Saudi Arabia
        5.8.5 Iran
        5.8.6 Others in Africa & Middle East

6 GlobalInactivated Vaccine by Players 2012-2017
    6.1 Global Inactivated Vaccine Sales Volume Market Share by Brands 2012-2017
    6.2 Global Inactivated Vaccine Revenue Share by Brands 2012-2017
    6.3 Global Top Players Inactivated Vaccine Key Product Model and Market Performance
    6.4 Global Top Players Inactivated Vaccine Key Target Consumers and Market Performance

7 EuropeInactivated Vaccine by Players 2012-2017
    7.1 Europe Inactivated Vaccine Sales Volume Market Share by Brands 2012-2017
    7.2 Europe Inactivated Vaccine Revenue Share by Brands 2012-2017
    7.3 Europe Top Players Inactivated Vaccine Key Product Model and Market Performance
    7.4 Europe Top Players Inactivated Vaccine Key Target Consumers and Market Performance

8 Global Inactivated Vaccine by Consumer 2012-2017
    8.1 Global Inactivated Vaccine Sales Market Share by Consumer 2012-2017
    8.2 Hospital
    8.3 Medical Center
    8.4 Consuming Habit and Preference

9 Europe Inactivated Vaccine by Consumer 2012-2017
    9.1 Europe Inactivated Vaccine Sales Market Share by Consumer 2012-2017
    9.2 Hospital
    9.3 Medical Center
    9.4 Consuming Habit and Preference

10 Global Inactivated Vaccine Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Inactivated Vaccine Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Inactivated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
    10.3 Global Inactivated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
    10.4 Global Inactivated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    10.5 Global Inactivated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)

11 Europe Inactivated Vaccine Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 Europe Inactivated Vaccine Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    11.2 Europe Inactivated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
    11.3 Europe Inactivated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
    11.4 Europe Inactivated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    11.5 Europe Inactivated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
List of Tables and Figures

    Table Global Inactivated Vaccine Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Global Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Inactivated Vaccine Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Global Inactivated Vaccine Sales (K Pcs) by End User (2012-2017)
    Table Global Inactivated Vaccine Sales Market Share by End User (2012-2017)
    Figure Global Inactivated Vaccine Sales Market Share by End User in 2016
    Table Global Inactivated Vaccine Revenue (Million USD) by End User (2012-2017)
    Table Global Inactivated Vaccine Revenue Market Share by End User (2012-2017)
    Figure Global Inactivated Vaccine Revenue Market Share by End User in 2016
    Table Global Inactivated Vaccine Price (USD/Pcs) by End User (2012-2017)
    Table Top Players of Pediatrics Inactivated Vaccine Products List
    Figure Global Pediatrics Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Adults Inactivated Vaccine Products List
    Figure Global Adults Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Inactivated Vaccine Sales (K Pcs) by Disease Indication (2012-2017)
    Table Global Inactivated Vaccine Sales Market Share by Disease Indication (2012-2017)
    Figure Global Inactivated Vaccine Sales Market Share by Disease Indication in 2016
    Table Global Inactivated Vaccine Revenue (Million USD) by Disease Indication (2012-2017)
    Table Global Inactivated Vaccine Revenue Market Share by Disease Indication (2012-2017)
    Figure Global Inactivated Vaccine Revenue Market Share by Disease Indication in 2016
    Table Global Inactivated Vaccine Price (USD/Pcs) by Disease Indication (2012-2017)
    Table Top Players of Pneumococcal Inactivated Vaccine Products List
    Figure Global Pneumococcal Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Influenza Inactivated Vaccine Products List
    Figure Global Influenza Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of HPV Inactivated Vaccine Products List
    Figure Global HPV Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Hepatitis Inactivated Vaccine Products List
    Figure Global Hepatitis Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Rotavirus Inactivated Vaccine Products List
    Figure Global Rotavirus Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Inactivated Vaccine Sales (K Pcs) by  (2012-2017)
    Table Global Inactivated Vaccine Sales Market Share by  (2012-2017)
    Figure Global Inactivated Vaccine Sales Market Share by  in 2016
    Table Global Inactivated Vaccine Revenue (Million USD) by  (2012-2017)
    Table Global Inactivated Vaccine Revenue Market Share by  (2012-2017)
    Figure Global Inactivated Vaccine Revenue Market Share by  in 2016
    Table Global Inactivated Vaccine Price (USD/Pcs) by  (2012-2017)
    Table Global Inactivated Vaccine Sales (K Pcs) by  (2012-2017)
    Table Global Inactivated Vaccine Sales Market Share by  (2012-2017)
    Figure Global Inactivated Vaccine Sales Market Share by  in 2016
    Table Global Inactivated Vaccine Revenue (Million USD) by  (2012-2017)
    Table Global Inactivated Vaccine Revenue Market Share by  (2012-2017)
    Figure Global Inactivated Vaccine Revenue Market Share by  in 2016
    Table Global Inactivated Vaccine Price (USD/Pcs) by  (2012-2017)
    Table Europe Inactivated Vaccine Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
    Figure Europe Inactivated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Europe Inactivated Vaccine Sales Volume (K Pcs) and Growth Rate (2012-2017)
    Table Europe Inactivated Vaccine Sales (K Pcs) by End User (2012-2017)
    Table Europe Inactivated Vaccine Sales Market Share by End User (2012-2017)
    Figure Europe Inactivated Vaccine Sales Market Share by End User in 2016
    Table Europe Inactivated Vaccine Revenue (Million USD) by End User (2012-2017)
    Table Europe Inactivated Vaccine Revenue Market Share by End User (2012-2017)
    Figure Europe Inactivated Vaccine Revenue Market Share by End User in 2016
    Table Europe Inactivated Vaccine Price (USD/Pcs) by End User (2012-2017)
    Table Top Players of Pediatrics Inactivated Vaccine Products List
    Figure Europe Pediatrics Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Adults Inactivated Vaccine Products List
    Figure Europe Adults Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Inactivated Vaccine Sales (K Pcs) by Disease Indication (2012-2017)
    Table Europe Inactivated Vaccine Sales Market Share by Disease Indication (2012-2017)
    Figure Europe Inactivated Vaccine Sales Market Share by Disease Indication in 2016
    Table Europe Inactivated Vaccine Revenue (Million USD) by Disease Indication (2012-2017)
    Table Europe Inactivated Vaccine Revenue Market Share by Disease Indication (2012-2017)
    Figure Europe Inactivated Vaccine Revenue Market Share by Disease Indication in 2016
    Table Europe Inactivated Vaccine Price (USD/Pcs) by Disease Indication (2012-2017)
    Table Top Players of Pneumococcal Inactivated Vaccine Products List
    Figure Europe Pneumococcal Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Influenza Inactivated Vaccine Products List
    Figure Europe Influenza Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of HPV Inactivated Vaccine Products List
    Figure Europe HPV Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Hepatitis Inactivated Vaccine Products List
    Figure Europe Hepatitis Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Top Players of Rotavirus Inactivated Vaccine Products List
    Figure Europe Rotavirus Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Inactivated Vaccine Sales (K Pcs) by  (2012-2017)
    Table Europe Inactivated Vaccine Sales Market Share by  (2012-2017)
    Figure Europe Inactivated Vaccine Sales Market Share by  in 2016
    Table Europe Inactivated Vaccine Revenue (Million USD) by  (2012-2017)
    Table Europe Inactivated Vaccine Revenue Market Share by  (2012-2017)
    Figure Europe Inactivated Vaccine Revenue Market Share by  in 2016
    Table Europe Inactivated Vaccine Price (USD/Pcs) by  (2012-2017)
    Table Europe Inactivated Vaccine Sales (K Pcs) by  (2012-2017)
    Table Europe Inactivated Vaccine Sales Market Share by  (2012-2017)
    Figure Europe Inactivated Vaccine Sales Market Share by  in 2016
    Table Europe Inactivated Vaccine Revenue (Million USD) by  (2012-2017)
    Table Europe Inactivated Vaccine Revenue Market Share by  (2012-2017)
    Figure Europe Inactivated Vaccine Revenue Market Share by  in 2016
    Table Europe Inactivated Vaccine Price (USD/Pcs) by  (2012-2017)
    Table Astellas Pharma (Japan) Company Details and Competitors
    Table Astellas Pharma (Japan) Key Inactivated Vaccine Models and Performance
    Table Astellas Pharma (Japan) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table Astellas Pharma (Japan) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Astellas Pharma (Japan) Inactivated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Astellas Pharma (Japan) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Astellas Pharma (Japan) Inactivated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Astellas Pharma (Japan) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table CSL Limited (Australia) Company Details and Competitors
    Table CSL Limited (Australia) Key Inactivated Vaccine Models and Performance
    Table CSL Limited (Australia) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table CSL Limited (Australia) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure CSL Limited (Australia) Inactivated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure CSL Limited (Australia) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure CSL Limited (Australia) Inactivated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure CSL Limited (Australia) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Emergent BioSolutions (U.S.) Company Details and Competitors
    Table Emergent BioSolutions (U.S.) Key Inactivated Vaccine Models and Performance
    Table Emergent BioSolutions (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table Emergent BioSolutions (U.S.) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Emergent BioSolutions (U.S.) Inactivated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Emergent BioSolutions (U.S.) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Emergent BioSolutions (U.S.) Inactivated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Emergent BioSolutions (U.S.) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table GlaxoSmithKline (U.K.) Company Details and Competitors
    Table GlaxoSmithKline (U.K.) Key Inactivated Vaccine Models and Performance
    Table GlaxoSmithKline (U.K.) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table GlaxoSmithKline (U.K.) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure GlaxoSmithKline (U.K.) Inactivated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline (U.K.) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure GlaxoSmithKline (U.K.) Inactivated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure GlaxoSmithKline (U.K.) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Johnson & Johnson (U.S.) Company Details and Competitors
    Table Johnson & Johnson (U.S.) Key Inactivated Vaccine Models and Performance
    Table Johnson & Johnson (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table Johnson & Johnson (U.S.) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Inactivated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Johnson & Johnson (U.S.) Inactivated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Johnson & Johnson (U.S.) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table MedImmune (U.S.) Company Details and Competitors
    Table MedImmune (U.S.) Key Inactivated Vaccine Models and Performance
    Table MedImmune (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table MedImmune (U.S.) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure MedImmune (U.S.) Inactivated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure MedImmune (U.S.) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure MedImmune (U.S.) Inactivated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure MedImmune (U.S.) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Merck & Co (U.S.) Company Details and Competitors
    Table Merck & Co (U.S.) Key Inactivated Vaccine Models and Performance
    Table Merck & Co (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table Merck & Co (U.S.) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Merck & Co (U.S.) Inactivated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Merck & Co (U.S.) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Merck & Co (U.S.) Inactivated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Merck & Co (U.S.) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Pfizer (U.S.) Company Details and Competitors
    Table Pfizer (U.S.) Key Inactivated Vaccine Models and Performance
    Table Pfizer (U.S.) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table Pfizer (U.S.) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Pfizer (U.S.) Inactivated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Pfizer (U.S.) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Pfizer (U.S.) Inactivated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Pfizer (U.S.) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Sanofi Pasteur (France) Company Details and Competitors
    Table Sanofi Pasteur (France) Key Inactivated Vaccine Models and Performance
    Table Sanofi Pasteur (France) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table Sanofi Pasteur (France) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Sanofi Pasteur (France) Inactivated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Sanofi Pasteur (France) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Sanofi Pasteur (France) Inactivated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Sanofi Pasteur (France) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Serum Institute of India Pvt (India) Company Details and Competitors
    Table Serum Institute of India Pvt (India) Key Inactivated Vaccine Models and Performance
    Table Serum Institute of India Pvt (India) Inactivated Vaccine Business SWOT Analysis and Forecast
    Table Serum Institute of India Pvt (India) Inactivated Vaccine Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
    Figure Serum Institute of India Pvt (India) Inactivated Vaccine Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Serum Institute of India Pvt (India) Inactivated Vaccine Sales Market Share (%) in Global (2012-2017)
    Figure Serum Institute of India Pvt (India) Inactivated Vaccine Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Serum Institute of India Pvt (India) Inactivated Vaccine Revenue Market Share (%) in Global (2012-2017)
    Table Global Inactivated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Global Inactivated Vaccine Sales Share by Regions (2012-2017)
    Figure Global Inactivated Vaccine Sales Market Share by Regions in 2016
    Figure Global Inactivated Vaccine Sales Market Share by Regions in 2017
    Table Global Inactivated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Table Global Inactivated Vaccine Revenue Market Share by Regions (2012-2017)
    Figure Global Inactivated Vaccine Revenue Market Share by Regions in 2016
    Figure Global Inactivated Vaccine Revenue Market Share by Regions in 2017
    Table Global Inactivated Vaccine Price (USD/Pcs) by Regions (2012-2017)
    Table North America Inactivated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table North America Inactivated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure North America Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Latin America Inactivated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Latin America Inactivated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Inactivated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Europe Inactivated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Asia & Pacific Inactivated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Asia & Pacific Inactivated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Africa & Middle East Inactivated Vaccine Sales (K Pcs) by Regions (2012-2017)
    Table Africa & Middle East Inactivated Vaccine Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Global Inactivated Vaccine Sales Volume (K Pcs) by Key Players 2012-2017
    Table Global Inactivated Vaccine Sales Volume Market Share by Key Players 2012-2017
    Figure Global Inactivated Vaccine Sales Volume Market Share by Key Players 2016
    Figure Global Inactivated Vaccine Sales Volume Market Share by Key Players 2017
    Table Global Inactivated Vaccine Revenue (Million USD) by Key Players 2012-2017
    Table Global Inactivated Vaccine Revenue Market Share by Key Players 2012-2017
    Figure Global Inactivated Vaccine Revenue Market Share by Key Players 2016
    Figure Global Inactivated Vaccine Revenue Market Share by Key Players 2017
    Table Global Top Players Key Product Model and Market Performance
    Table Global Top Players Key Target Consumers and Market Performance
    Table Europe Inactivated Vaccine Sales Volume (K Pcs) by Key Players 2012-2017
    Table Europe Inactivated Vaccine Sales Volume Market Share by Key Players 2012-2017
    Figure Europe Inactivated Vaccine Sales Volume Market Share by Key Players 2016
    Figure Europe Inactivated Vaccine Sales Volume Market Share by Key Players 2017
    Table Europe Inactivated Vaccine Revenue (Million USD) by Key Players 2012-2017
    Table Europe Inactivated Vaccine Revenue Market Share by Key Players 2012-2017
    Figure Europe Inactivated Vaccine Revenue Market Share by Key Players 2016
    Figure Europe Inactivated Vaccine Revenue Market Share by Key Players 2017
    Table Europe Top Players Key Product Model and Market Performance
    Table Europe Top Players Key Target Consumers and Market Performance
    Table Global Inactivated Vaccine Sales (K Pcs) by Consumer (2012-2017)
    Figure Global Inactivated Vaccine Sales Market Share by Consumer (2012-2017)
    Figure Global Inactivated Vaccine Sales Market Share by Consumer in 2016
    Figure Global Hospital Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Medical Center Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Table Europe Inactivated Vaccine Sales (K Pcs) by Consumer (2012-2017)
    Figure Europe Inactivated Vaccine Sales Market Share by Consumer (2012-2017)
    Figure Europe Inactivated Vaccine Sales Market Share by Consumer in 2016
    Figure Europe Hospital Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Europe Medical Center Inactivated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Global Inactivated Vaccine Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Global Inactivated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Inactivated Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Global Inactivated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Global Inactivated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Inactivated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Inactivated Vaccine Sales Volume Share Forecast by Regions in 2022
    Table Global Inactivated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Global Inactivated Vaccine Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Inactivated Vaccine Sales Volume Market Share Forecast by Application in 2022
    Table Global Inactivated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    Figure Global Inactivated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    Figure Global Inactivated Vaccine Sales Volume Market Share Forecast by End User in 2022
    Table Global Inactivated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
    Figure Global Inactivated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
    Figure Global Inactivated Vaccine Sales Volume Market Share Forecast by Disease Indication in 2022
    Figure Europe Inactivated Vaccine Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
    Figure Europe Inactivated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Europe Inactivated Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
    Table Europe Inactivated Vaccine Sales (K Pcs) Forecast by Regions (2017-2022)
    Table Europe Inactivated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
    Figure Europe Inactivated Vaccine Sales Volume Share Forecast by Regions (2017-2022)
    Figure Europe Inactivated Vaccine Sales Volume Share Forecast by Regions in 2022
    Table Europe Inactivated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
    Figure Europe Inactivated Vaccine Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Europe Inactivated Vaccine Sales Volume Market Share Forecast by Application in 2022
    Table Europe Inactivated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    Figure Europe Inactivated Vaccine Sales (K Pcs) Forecast by End User (2017-2022)
    Figure Europe Inactivated Vaccine Sales Volume Market Share Forecast by End User in 2022
    Table Europe Inactivated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
    Figure Europe Inactivated Vaccine Sales (K Pcs) Forecast by Disease Indication (2017-2022)
    Figure Europe Inactivated Vaccine Sales Volume Market Share Forecast by Disease Indication in 2022 



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likely

Read More...

Global compressed air treatment equipment market is projected to reach USD 8.59 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing implementation of this equipment in various industry sectors such as healthcare & pharmace

Read More...

Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energ

Read More...

Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous indust

Read More...

Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among ot

Read More...
Choose License Type
Single User - US $2960
Multi User - US $5920
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify